These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 2592987)
1. Anti-neuroblastoma antibodies in myasthenia gravis: clinical and immunological correlations. Müller KM J Neurol Sci; 1989 Nov; 93(2-3):263-75. PubMed ID: 2592987 [TBL] [Abstract][Full Text] [Related]
2. Antibodies against human neuroblastoma cells in the sera of patients with myasthenia gravis. Müller KM; Andersson LC J Neuroimmunol; 1984 Dec; 7(2-3):97-105. PubMed ID: 6210305 [TBL] [Abstract][Full Text] [Related]
3. Effect of thymectomy and immunosuppressive therapy on anti-neuroblastoma antibody levels in patients with myasthenia gravis. Müller KM; Nykyri E; Andersson LC Acta Neurol Scand; 1991 May; 83(5):336-42. PubMed ID: 2063657 [TBL] [Abstract][Full Text] [Related]
4. Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients. Yamamoto AM; Gajdos P; Eymard B; Tranchant C; Warter JM; Gomez L; Bourquin C; Bach JF; Garchon HJ Arch Neurol; 2001 Jun; 58(6):885-90. PubMed ID: 11405802 [TBL] [Abstract][Full Text] [Related]
5. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis. Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539 [TBL] [Abstract][Full Text] [Related]
6. Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor. Shiono H; Wong YL; Matthews I; Liu JL; Zhang W; Sims G; Meager A; Beeson D; Vincent A; Willcox N Int Immunol; 2003 Aug; 15(8):903-13. PubMed ID: 12882828 [TBL] [Abstract][Full Text] [Related]
7. Anti-skeletal muscle and anti-acetylcholine receptor antibodies in patients with thymoma without myasthenia gravis: relation to the onset of myasthenia gravis. Ohta M; Itoh M; Hara H; Itoh N; Nishitani H; Hayashi K; Ohta K Clin Chim Acta; 1991 Sep; 201(3):201-5. PubMed ID: 1756593 [TBL] [Abstract][Full Text] [Related]
8. [Antibodies in myasthenia gravis]. Eymard B Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288 [TBL] [Abstract][Full Text] [Related]
9. Myasthenia gravis: antibodies to acetylcholine receptor with human and rat antigens. Oda K; Goto I; Kuroiwa Y; Onoue K; Ito Y Neurology; 1980 May; 30(5):543-6. PubMed ID: 7189261 [TBL] [Abstract][Full Text] [Related]
10. Improved radioassay of anti-acetylcholine receptor antibody: application for the detection of extremely low antibody titers in sera from patients with myasthenia gravis. Ohta M; Ohta K; Mori F; Itoh N; Nishitani H; Hayashi K Clin Chem; 1990 Jun; 36(6):911-3. PubMed ID: 2357833 [TBL] [Abstract][Full Text] [Related]
11. Anti-AChR antibodies, thymic histology, and T cell subsets in myasthenia gravis. Berrih S; Morel E; Gaud C; Raimond F; Le Brigand H; Bach JF Neurology; 1984 Jan; 34(1):66-71. PubMed ID: 6228745 [TBL] [Abstract][Full Text] [Related]
12. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies. Romi F; Skeie GO; Aarli JA; Gilhus NE Arch Neurol; 2000 Nov; 57(11):1596-600. PubMed ID: 11074791 [TBL] [Abstract][Full Text] [Related]
13. Antibodies to synthetic peptide (125-148) of the alpha-subunit of human nicotinic acetylcholine receptor in sera from patients with myasthenia gravis. Ohta M; Ohta K; Itoh N; Nishitani H; Hara H; Hayashi K Neurology; 1990 Nov; 40(11):1776-8. PubMed ID: 2234435 [TBL] [Abstract][Full Text] [Related]
14. Correlation between acetylcholine receptor antibody levels and thymic pathology in myasthenia gravis: a review. Huang GZ; Lo YL J Clin Neuromuscul Dis; 2013 Jun; 14(4):209-17. PubMed ID: 23703018 [TBL] [Abstract][Full Text] [Related]
15. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor. Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424 [TBL] [Abstract][Full Text] [Related]
16. Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis. Howard FM; Lennon VA; Finley J; Matsumoto J; Elveback LR Ann N Y Acad Sci; 1987; 505():526-38. PubMed ID: 3479935 [TBL] [Abstract][Full Text] [Related]
17. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Lindstrom JM; Seybold ME; Lennon VA; Whittingham S; Duane DD Neurology; 1976 Nov; 26(11):1054-9. PubMed ID: 988512 [TBL] [Abstract][Full Text] [Related]
18. Acetylcholine receptor antibody characteristics in myasthenia gravis. III. Patients with low anti-AChR antibody levels. Vincent A; Newsom-Davis J Clin Exp Immunol; 1985 Jun; 60(3):631-6. PubMed ID: 2410169 [TBL] [Abstract][Full Text] [Related]
19. Anti-acetylcholine-receptor antibody concentrations after thymectomy in patients with myasthenia gravis. Seybold ME; Baergen RN; Nave B; Lindstrom JM Br Med J; 1978 Oct; 2(6144):1051-3. PubMed ID: 709215 [TBL] [Abstract][Full Text] [Related]
20. Antimuscle and antiacetylcholine receptor antibodies in myasthenia gravis. Penn AS; Schotland DL; Lamme S Muscle Nerve; 1986 Jun; 9(5):407-15. PubMed ID: 3724787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]